David Gionco Insider Trading
Get free email notifications about insider trading for David Gionco.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David Gionco. David Gionco is a Group Vice President, CFO in SAVIENT PHARMACEUTICALS INC ($SVNT) and a Group VP & CFO in SAVIENT PHARMACEUTICALS INC ($SVNT) and a Group VP, CFO in SAVIENT PHARMACEUTICALS INC ($SVNT) and a VP, CFO in SAVIENT PHARMACEUTICALS INC ($SVNT) and a Chief Accounting Officer in STEMLINE THERAPEUTICS INC ($STML).
Over the past year David Gionco has been an insider in 1 company. The total value of shares held by David Gionco in this company amounts to $1,397,902.
David Gionco ranks 14,837 out of 350,000 insiders. Go to Insider Ranking to see more.
Address: SAVIENT PHARMACEUTICALS, INC. ONE TOWER CENTER, 14TH FLOOR EAST BRUNSWICK 08816 NJ
Companies in which David Gionco is an Insider
SAVIENT PHARMACEUTICALS INC
Industry: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
Position of David Gionco: Group Vice President, CFO, Group VP & CFO, Group VP, CFO
Holdings: 42,735 shares
Current Value: $2,008,545
Latest Transaction: Jan 27 2011
$SVNT Market Capitalization: $1.02B
$SVNT Previous Close: $47.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
STEMLINE THERAPEUTICS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of David Gionco: Chief Accounting Officer
Holdings: 225,468 shares
Current Value: $1,397,902
Latest Transaction: Mar 15 2019
$STML Market Capitalization: $118.68M
$STML Previous Close: $6.20
Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions
Last 3 Months Overview:
Buy: 5x
Sell: 18x
Shares Bought: 201,450
Shares Sold: 73,122
Share Difference: +128,328
Value Difference: +$953,515
Latest Insider Trading Transactions of David Gionco
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 15 2019 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 11.05 | 530 | 5,857 | 224,938 | 225.5 K to 224.9 K (-0.24 %) |
| Mar 15 2019 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 11.11 | 13,492 | 149,896 | 225,468 | 239 K to 225.5 K (-5.65 %) |
| Mar 08 2019 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 11.32 | 1,381 | 15,633 | 238,960 | 240.3 K to 239 K (-0.57 %) |
| Mar 08 2019 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 11.32 | 1,381 | 15,633 | 238,960 | 240.3 K to 239 K (-0.57 %) |
| Feb 27 2019 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 12.03 | 8,563 | 103,013 | 240,341 | 248.9 K to 240.3 K (-3.44 %) |
| Feb 08 2019 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Grant | A | 0.00 | 9,009 | 0 | 248,904 | 239.9 K to 248.9 K (+3.76 %) |
| Feb 08 2019 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Grant | A | 0.00 | 69,550 | 0 | 239,895 | 170.3 K to 239.9 K (+40.83 %) |